Outinen et al, 1998)
Broader indications beyond diabetes and obesity, including MASH and OSA [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Longer dosing intervals between administrations [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Increasing availability in oral form [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Improved efficacy compared with existing therapies [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Existing GLP-1 products in Canada include Ozempic, Wegovy and Rybelsus from Novo Nordisk, alongside Mounjaro and Zepbound from Eli Lilly
Disruption of proteostasis is now recognized as a core pathological mechanism across cardiomyopathies, ischemic heart disease, arrhythmias, and heart failure, linking molecular protein quality control failure to tissue remodeling and clinical disease progression
Indications Dull and uneven body skin tone Body pigmentation (knees, elbows, intertriginous) Adjunct to facial depigmenting therapy Post-tanning skin maintenance Mechanism of Action Kojic Acid chelates copper at tyrosinase
If you have pernicious anemia, make sure youre using the methylcobalamin form of B12
